Zoledronic Acid Prevents Bone Loss in Premenopausal Women Undergoing Adjuvant Chemotherapy for Early-Stage Breast Cancer

PURPOSE: Adjuvant chemotherapy for breast cancer (BC) may be associated with increased rates of bone loss and decreased bone mineral density (BMD) and may lead to premature osteoporosis and increased fracture risk. We examined whether zoledronic acid (ZA) prevents bone loss in premenopausal women re...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hershman, Dawn L., McMahon, Donald J., Crew, Katherine D., Cremers, Serge, Irani, Dinaz, Cucchiara, Gina, Brafman, Lois, Shane, Elizabeth
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2008
Assuntos:
Breast Cancer
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2653138/
https://ncbi.nlm.nih.gov/pubmed/18711172
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2008.16.4707
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados